IBA reports reduced half-year revenues

2019 09 21 00 44 1021 Iba Astro 2019

Proton therapy developer Ion Beam Applications (IBA) reported reduced revenues for the first half of 2020, which it attributed to challenges presented by the COVID-19 pandemic.

The company posted revenue of 109.7 million euros for the period, down 14.3% compared with 128 million euros for the same period in 2019.

With respect to recurring earnings before interest and taxes (REBIT), the company posted a net loss for the first half of 9.9 million euros, compared with a net loss of 4.4 million euros in the same period the year before.

Page 1 of 547
Next Page